‼️ The @US_FDA is fast-tracking drug approvals at record speed!
“We just approved the two fastest drugs in history…one in 45 days the other in 55 days.”—@SecKennedy
There's a better way. ➡️ https://www.fda.gov/news-events/press-announcements/fda-achieves-year-1-goals-reducing-animal-testing-drug-development
Just published: FDA moves from vision to real progress. @JAMA_current
https://jamanetwork.com/journals/jama/fullarticle/2848148?resultClick=1
In year 1 of its Roadmap to Reducing Animal Testing, the FDA has successfully launched several key initiatives and advanced human-relevant alternatives. Replacing outdated methods with cutting-edge approaches that better predict safety and efficacy is the future of science: https://www.fda.gov/news-events/press-announcements/fda-achieves-year-1-goals-reducing-animal-testing-drug-development
Making the switch to real foods CAN be done affordably. Thanks to this school for leading the way.
The FDA’s AI stance in action!
The agency just cleared an AI ultrasound tool that estimates gestational age in under 2 minutes.
This is the model: support innovation that expands access and improves speed, while holding firm on safety and effectiveness.
AI isn’t being slowed, it’s being cleared forward with guardrails.
FDA is moving proactively to advance potential therapies to address America’s mental health crisis.
It’s time for new approaches.
.@DrMakaryFDA: "Today, the @US_FDA is also announcing the first ibogaine investigational new drug clearance. This will pave the way for the first ever human trials in the United States."
Amazing things can happen when we replace ultraprocessed foods with real foods. At this school, pesticide and heavy metal levels dropped 50-90%.
Thank you, @Gatorade, for removing artificial FD&C colors and switching to newly @US_FDA–approved plant-based dyes from fruits and vegetables. I urge every food company to follow your lead and join us to Make America Healthy Again.
Missed the #FDAGrandRounds on the Modernization of Cosmetics Regulation Act? The recording is now available! FDA experts from the Office of Cosmetics & Colors share everything you need to know about this landmark legislation. Watch here: https://www.youtube.com/watch?v=Ykcm-Lua2-M
The FDA is moving forward on men's health by encouraging sponsors of approved testosterone replacement therapy products to explore a potential new use—treating low libido in men with idiopathic hypogonadism. https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men
Emerging data suggest this may help men experiencing symptoms that affect quality of life.
The agency is committed to advancing treatment options while maintaining rigorous safety and effectiveness standards.
@US_FDA chemists stationed at international mail facilities are stopping counterfeit and potentially lethal drugs before they reach Americans. Five satellite labs across the country analyze suspicious imports daily. See how this critical work protects public health:
https://www.fda.gov/news-events/fda-voices/fda-scientists-working-satellite-laboratories-across-us-help-prevent-harmful-drugs-reaching
During @DrMakaryFDA’s first year, @US_FDA approvals across the board exceeded historical averages.
Meet Imogene Gollinger, the FDA’s first woman field investigator. Her legacy highlights the power of resilience, adaptability, & the vital role of investigators in advancing the FDA’s mission. Her work continues to inspire today. https://bit.ly/48O31MW.
#FDA #PublicHealth
RT @HHSResponse: In @DrMakaryFDA's first year, the @US_FDA had record numbers of approvals.
🔥 67 new medications
🔥 39 new devices
🔥 91 new…
Reminder – registration is closing on April 24 for those who want to speak at the FDA’s June 4 public hearing on the Commissioner’s National Priority Voucher (CNPV) program—a fast review pathway for drugs of national importance. For more information: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/registration-commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing
Fixing America’s Food System - Robert Irvine
In this episode of The Secretary Kennedy Podcast, I sit down with Chef @RobertIrvine to talk about how we can transform America’s food system without increasing costs. We discuss why real food is more affordable than people think, how better purchasing and preparation can deliver healthier meals at scale, and what his work with the U.S. military reveals about improving nutrition, performance, and long-term health.
This conversation focuses on practical solutions to reduce chronic disease, support families, and restore real food to schools, hospitals, and communities across the country.
Curious about menopausal hormone therapy (MHT)? Join @FDAWomen and @FDA_Drug_Info on 4/23 for #FDAGroundRounds to explore:
✅ The history of MHT regulation
✅ Recent labeling updates to MHT
✅ What these changes mean for #WomensHealth
Learn More: https://www.fda.gov/science-research/fda-grand-rounds/fda-grand-rounds-presented-office-womens-health-fda-menopausal-hormone-therapy-mht-labeling
This administration is serious about protecting the border.
FDA‘s inspectors are an invisible front line against dangerous, illegal products trying to enter our country.
The FDA has shifted into a higher gear.
Negative trial results often go unreported by companies and researchers, leaving significant gaps in the public record. Reporting results is not optional—it’s a legal and ethical obligation that helps protect patients and strengthen scientific integrity. https://www.fda.gov/news-events/press-announcements/fda-reminds-more-2200-sponsors-and-researchers-disclose-trial-results
The FDA has reminded over 2,200 medical product companies and researchers of their legal requirement to submit clinical trial results to http://ClinicalTrials.gov. Currently, 29.6% of required trial results are missing from the database. Transparency in research is essential to protect patients and advance science. https://www.fda.gov/news-events/press-announcements/fda-reminds-more-2200-sponsors-and-researchers-disclose-trial-results
In 2025 we tested 102 samples of honey for hidden sweeteners. Most honey passed the test—but even a small amount of fraud matters.
We’re staying vigilant to protect the integrity of your food.
https://www.fda.gov/food/hfp-constituent-updates/fda-releases-fy25-sampling-results-economically-motivated-adulteration-honey
FDA issued a warning letter to a Texas medical spa for failing to follow federal requirements designed to ensure prescription drugs are safe, traceable, and come from verified sources. These safeguards help protect patients from counterfeit or unsafe products. Learn more: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pure-indulgence-aesthetics-723267-04012026
We’re seeing companies slap bogus labels on unapproved GLP-1s and other drugs. We take these violations seriously.
FDA has issued 7 warning letters linked to 20+ violative products with concerns about GLP-1 and other products sold to consumers marked for “research purposes” or “not for human consumption”. These products may pose serious health risks. Do not use or purchase unapproved GLP-1 products marketed for research purposes. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
FDA’s inspectors and investigators protect Americans from a wide variety fake, dangerous, and illegal drugs, supplements and more.
Thank you to this team in Miami for showing me around their facility!
We’re lowering drug prices and getting decisions out efficiently.
Join us for FDA Grand Rounds on April 9. Dr. Richard Beger, Branch Chief of the OMIC branch in NCTR’s Division of Systems Biology, will provide an overview of Systems Biology omics and biomarker concepts with four examples of omics analyses of human blood samples. CME offered. http://www.FDA.gov/GrandRounds
The FDA is making it easy for food companies to stop using artificial petroleum-based food dyes.
FDA is moving at the pace of innovation.
🗓️ Registration is now OPEN!
The FDA is seeking public input on the Commissioner’s National Priority Voucher (CNPV) program—a fast review pathway for drugs of national importance.
Join us June 4 (rescheduled from June 12) for a public hearing:
https://www.fda.gov/news-events/commissioners-national-priority-voucher-cnpv-pilot-program-public-hearing-06122026
After one year as commissioner, @DrMakaryFDA expressed his appreciation at an all-hands FDA Town Hall this afternoon.
Recapping a year's worth of progress, taking a moment to recognize our amazing staff, and discussing what's next for @US_FDA.
The American people deserve an FDA that is responsive and efficient.
Five drugs have been approved so far under the national priority voucher pilot program, which helps the agency move efficiently on applications that advance Americans’ key interests.
Today the FDA issued its fastest approval for a novel drug (NME) since 2002, as part of the national priority voucher pilot program.
✔️ New option for chronic weight management
✔️ Full FDA review completed in 50 days
✔️ 5th national priority voucher approval
Learn more: https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program
The new FDA is delivering more efficient drug reviews for the American people.
The @US_FDA is seeking comments from the public on various topics pertaining to the regulation of cosmetics in preparation for the 20th International Cooperation on Cosmetics Regulation annual meeting in July. For more information, visit https://www.federalregister.gov/documents/2026/03/18/2026-05280/preparation-for-international-cooperation-on-cosmetics-regulation-twentieth-annual-meeting-iccr-20.